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Abstract. Twenty trihaloacetylazulene derivatives with one
atom of fluorine, chlorine, bromine or iodine was investigated
for their tumor-specific cytotoxicity and apoptosis-inducing
activity against three human normal cells (gingival fibroblast,
HGF; pulp cell, HPC; periodontal ligament fibroblast, HPLF)
and four human tumor cell lines (squamous cell carcinoma,
HSC-2, HSC-3, HSC-4; promyelocytic leukemia, HL-60).
There was no apparent difference in the cytotoxic activity
between 2-methoxyazulenes [1a-1e, 2a-2e] and 2-
ethoxyazulenes [3a-3e, 4a-4e]. Trichloroacetylazulenes [2a-2e,
4a-4e] generally showed higher cytotoxicity and tumor-
specificity (expressed as a TS value) as compared with the
corresponding trifluoroacetylazulenes [1a-1e, 3a-3e].
Substitution of chloride [1c, 2c, 3c. 4c], bromide [1d, 2d, 3d,
4d] or iodine [1e, 2e, 3e, 4e] at the C-3 position further
enhanced cytotoxic activity against four tumor cell lines,
especially HL-60 cells. Among twenty trihaloacetylazulene
derivatives, two compounds [2d] and [4c] showed the highest
tumor specificity (TS=>3.5 and >2.5, respectively).
Compounds [2d] and [4c] induced apoptotic cell death
characterized by caspase-3, -8 and -9 activation and
internucleosomal DNA fragmentation in HL-60 cells. On the
other hand, compounds [2d] and [4c] induced autophagic cell
death characterized by lower activation of caspases, lack of
DNA fragmentation, vacuolization and autophagosome
formation detected by acridine orange and LC3-GFP
fluorescence, without the decline of the intracellular
concentration of three major polyamines in HSC-4 cells. The
cytotoxic activity of [4c], but not [2d], was slightly reduced by
3-methyladenine, an inhibitor of autophagy. These results
suggest the diversity of cell death type induced in human tumor
cell lines by trihaloacetylazulene derivatives. 
Azulene (1-4), an isomer to naphthalene, has a dipole moment
and a resonance energy with intermediate values between that
of benzene and naphthalene, and is considerably more
reactive, when compared with the two arenes. Azulene
derivatives have been investigated in the past for their synthesis
and chemical reactions (5-7). Their derivatives have shown
several biological activities, including antibacterial activity (8),
anti-ulcer activity (9), relaxant activity (10), inhibition of
thromboxane A2-induced vasoconstriction and thrombosis
(11), acute toxicity and local anesthetic activity (12), and
chemotherapeutic activity against mucous membrane diseases
(13, 14). We have recently shown the quantitative structure-
activity relationship (QSAR) of a total of 81 azulene (15, 16),
tropolone (17, 18) and azulenequinone (19, 20) derivatives. We
found that 1,3-difluoroazulene (15), 2,4-dibromo-7-
methoxytropone (17), 3-morpholino-1,5-azulenequinone and
3,7-dibromo-1,5-azulenequinone (19) inhibited the NO
production by activated mouse macrophages, without (15) or
with (17, 19) the inhibition of iNOS mRNA and protein
expression. We also found that 2-acetylaminoazulene, diethyl
2-chloroazulene-1,3-dicarboxylate and methyl 7-isopropyl-2-
methoxyazulene-1-carboxylate showed higher tumor-specific
cytotoxicity than the parent compounds, such as azulene and
guaiazulene (16). Tropolone derivatives with phenolic OH
group, hinokithiol, its tosylate and methyl ethers showed
relatively higher tumor-specific cytotoxic activity (18). 3-
(3-Guaiazulenyl)-1,5-azulenequinone and 7-isopropyl-3-
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(4-methylanilino)-2-methyl-1,5-azulenequinone showed
relatively higher tumor-specific cytotoxicity and induced
apoptosis in human tumor cell lines, possibly via the activation
of both mitochondria-independent (extrinsic) and -dependent
(intrinsic) pathways (20). 
It has been reported that hexafluorotrihydroxyvitamin
D3 derivatives show higher differentiation-inducing
activity (21, 22) than the parent compound (21, 22). We
have also recently reported that thirteen
trichloroacetylazulenes showed higher tumor-specific
cytotoxic activity than the corresponding thirteen
trifluoroacetylazulenes (23). These results suggest that the
introduction of halogen may enhance the biological
activity of the parent compound. However, it is still not
clear whether the introduction of other halogens shows a
similar enhancing effect. In this study, therefore, twenty
trihaloacetylazulene derivatives with one atom of fluorine,
chlorine, bromine or iodine (Figure 1) were investigated
for their tumor-specific cytotoxicity and apoptosis-
inducing activity against three human normal cells
(gingival fibroblast, HGF; pulp cell, HPC; periodontal
ligament fibroblast, HPLF) and four human tumor cell
lines (oral squamous cell carcinoma, HSC-2, HSC-3, HSC-
4; promyelocytic leukemia, HL-60). 
Materials and Methods
Materials. The following chemicals and reagents were obtained
from the indicated companies: Dulbeccos’s modified Eagle’s
medium (DMEM), RPMI 1640 (Sigma Chem. Co., St. Louis, MO,
USA); fetal bovine serum (FBS) (JRH, Bioscience, Lenexa, KS,
USA), dimethyl sulfoxide (DMSO), trichloroacetic acid (TCA)
(Wako Pure Chem, Ind, Ltd, Osaka, Japan); 3-(4,5-
dimethylthiazol-2-yl)-2,2-diphenyltetrazolium bromide (MTT)
(Sigma Chem Co., St. Louis, MO, USA).
Synthesis of trihaloacetylazulenes. Trihaloacetylazulene derivatives
were synthesized, according to methods previously published: 1-
trifluoroacetyl-2-methoxyazulene [1a] (24-27), 1-trifluoroacetyl-3-
fluoro-2-methoxyazulene [1b] (25, 28-30), 1-trifluoroacetyl-3-
chloro-2-methoxyazulene [1c] (25, 31-34), 1-trifluoroacetyl-3-
bromo-2-methoxyazulene [1d] (25, 31-34), 1-trifluoroacetyl-3-iodo-
2-methoxyazulene [1e] (25, 31, 32), 1-trichloroacetyl-2-
methoxyazulene [2a] (24-27), 1-trichloroacetyl-3-fluoro-2-
methoxyazulene [2b] (25, 28-30), 1-trichloroacetyl-3-chloro-2-
methoxyazulene [2c] (25, 31-34), 1-trichloroacetyl-3-bromo-2-
methoxyazulene [2d] (25, 31-34), 1-trichloroacetyl-3-iodo-2-
methoxyazulene [2e] (25, 31, 32), 1-trifluoroacetyl-2-ethoxyazulene
[3a] (24-27, 34), 1-trifluoroacetyl-2-ethoxy-3-fluoroazulene [3b]
(25, 28-30), 1-trifluoroacetyl-3-chloro-2-ethoxyazulene [3c] (25, 31-
34), 1-trifluoroacetyl-3-bromo-2-ethoxyazulene [3d] (25, 31-34), 1-
trifluoroacetyl-2-ethoxy-3-iodoazulene [3e] (25, 31, 32), 1-
trichloroacetyl-2-ethoxyazulene [4a] (24-27, 34), 1-trichloroacetyl-
2-ethoxy-3-fluoroazulene [4b] (25, 28-30), 1-trichloroacetyl-3-
chloro-2-ethoxyazulene [4c] (25, 31-34), 1-trichloroacetyl-3-bromo-
2-ethoxyazulene [4d] (25, 31,-34), 1-trichloroacetyl-2-ethoxy-3-
iodoazulene [4e] (25, 31, 32) (Figure 1).
Cell culture. Three human oral tumor cell lines (HSC-2, HSC-3,
HSC-4) and three human normal cells (HGF, HPC, HPLF) were
cultured in DMEM supplemented with 10% heat-inactivated FBS.
Human promyelocytic leukemic HL-60 cells were cultured in
RPMI 1640 supplemented with 10% heat-inactivated FBS. Tumor
cell lines were obtained from the Riken Cell Bank. Normal cells
were prepared from the periodontal tissues, according to the
guidelines of the Institutional Board of Meikai University Ethic
Committee (No. 0206) after obtaining the informed consent from
the patients. Since HGF, HPC and HPLF cells have limited
lifespan due to in vitro senescence (35), these cells were used at the
population doubling level of 5-8 for the present study. 
Assay for cytotoxic activity. Cells (other than HL-60 cells) were
inoculated at 5x103 cells/well in 96-microwell (Becton Dickinson
Labware, NJ, USA), unless otherwise stated. After 48 hours, the
medium was removed by suction with an aspirator, and replaced with
0.1 mL of fresh medium containing various concentrations of test
compounds. The first well contained 500 ÌM of the sample, and was
diluted 2-fold sequentially, with three replicate wells for each
concentration. Cells were incubated for another 24 hours, and the
relative viable cell number was then determined by the MTT method.
In brief, cells were washed with phosphate-buffered saline without
calcium and magnesium (PBS(-)), replaced with fresh culture medium
containing 0.2 mg/mL MTT and incubated for another four hours.
The cells were lysed with 0.1 mL of DMSO, and the absorbance at 540
nm of the cell lysate was determined, using a microplate reader
(Biochromatic Labsystem, Helsinki, Finland) (16, 18, 20). A540 of the
control cells was usually in the range from 0.40 to 0.90. 
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Figure 1. Structure of the ten trifluoroacetylazulenes [1a-1e, 3a-3e] and
ten trichloroacetylazulenes [2a-2e, 4a-4e]. 
HL-60 cells were inoculated at 7.5x104/0.1 mL in 96-microwell,
and various concentrations of test compounds were added. After
incubation for 24 hours, the viable cell number was determined by
trypan blue exclusion, under a light microscope. 
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Table I. Cytotoxic activity of trihaloacetylazulenes.
Cytotoxic activity (CC50:ÌM)
Normal human cells Human tumor cell lines
Compd. MW. HGF HPLF HPC HSC-2 HSC-3 HSC-4 HL-60 TS
[1a] 254.2 >500.0 >500.0 >500.0 449.0 >481.0 >478.6 >293.1 ><1.2
[1b] 272.2 >500.0 >500.0 >500.0 >500.0 496.9 >500.0 >432.5 ><1.0
[1c] 288.7 >166.7 >166.7 >166.7 150.1 147.2 >166.7 84.5 ><1.2
[1d] 333.1 >500.0 >498.1 >500.0 >500.0 453.6 >500.0 79.4 ><1.3
[1e] 380.1 >500.0 >500.0 >500.0 >412.7 308.0 >500.0 56.5 ><1.6
[2a] 303.6 >437.9 >442.1 382.5 281.6 331.3 331.5 53.8 >1.7
[2b] 321.6 >466.6 398.6 390.9 288.8 249.4 254.7 35.8 >2.0
[2c] 338.0 192.3 264.2 259.1 199.2 148.8 58.9 <4.3 >2.3
[2d] 382.5 >175.8 >228.3 191.2 97.7 82.8 38.3 6.5 >3.5
[2e] 429.5 125.1 >152.0 >144.6 101.9 124.8 96.6 16.9 >1.7
[3a] 268.3 >495.6 >500.0 >500.0 >452.4 >500.0 >500.0 >426.2 ><1.1
[3b] 286.2 >500.0 >500.0 >500.0 325.8 >489.9 >500.0 290.9 ><1.2
[3c] 302.7 >500.0 >500.0 >500.0 >291.2 >392.4 >442.4 112.7 ><1.6
[3d] 347.1 >166.7 >166.7 >166.7 >152.7 >166.7 >166.7 >152.4 ><1.0
[3e] 394.1 >138.8 >166.7 >166.7 >135.9 >155.0 >166.7 86.1 ><1.2
[4a] 317.6 >461.6 419.3 >457.9 214.2 273.6 339.4 71.3 >2.0
[4b] 335.6 390.0 363.5 386.2 223.3 244.8 440.4 30.0 1.6
[4c] 352.0 161.3 190.6 222.7 88.4 100.6 113.4 <4.2 >2.5
[4d] 396.5 92.8 79.2 150.0 57.1 94.3 66.2 <3.9 >1.9
[4e] 443.5 117.8 118.1 108.6 81.8 67.0 73.8 3.1 2.0
Each value represents mean from 3-6 independent experiments. MW: molecular weight; TS: tumor-specificity.
Figure 2. Activation of caspases-3, -8 and -9 by two trichloroacetylazulenes [2d, 4c]. HL-60 and HSC-4 cells were incubated for 4 hours without (control)
or with the indicated concentrations of [2d] or [4c] or 1 Ìg/mL actinomycin D (Act-D) (positive control). Each point represents mean±S.D. from 3-4
independent experiments.
The 50% cytotoxic concentration (CC50) was determined from
the dose-response curve. Tumor-specificity (TS) was determined
by the following equation: TS={[CC50 (HGF) + CC50 (HPC) +
CC50 (HPLF)] / [CC50 (HSC-2) + CC50 (HSC-3) + CC50 (HSC-4)
+ CC50 (HL-60)]} x (4/3)
Assay for DNA fragmentation. Cells were washed once with PBS (-)
and lysed with 50 ÌL lysate buffer [50 mM Tris-HCl (pH 7.8), 10 mM
EDTA, 0.5% (w/v) sodium N-lauroyl sarcosinate solution]. The
solution was incubated with 0.4 mg/mL RNase A and 0.8 mg/mL
proteinase K for 1-2 hours at 50ÆC, and then mixed with 50 ÌL NaI
solution [7.6 M NaI, 20 mM EDTA-2Na, 40 mM Tris-HCl, pH 8.0],
and then 200 ÌL of ethanol. After centrifugation for 20 minutes at
20,000 xg, the precipitate was washed with 1 mL of 70% ethanol and
dissolved in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0).
Sample (10-20 ÌL) was applied to 2% agarose gel electrophoresis in
TBE buffer (89 mM Tris-HCl, 89 mM boric acid, 2 mM EDTA, pH
8.0). DNA molecular marker (Bayou Biolabs, Harahan, LA, USA)
and DNA from apoptotic HL-60 cells induced by 1 Ìg/mL
actinomycin D were run in parallel (16, 18, 20). After staining with
ethidium bromide, DNA was visualized by UV irradiation, and
photographed by CCD camera (Bio Doc Inc, UVP).
Assay for caspase activation. Cells were washed with PBS(-) and
lysed in lysis solution (MBL, Nagoya, Japan). After standing for
ten minutes on ice and centrifugation for 5 minutes at 10,000 xg,
the supernatant was collected. Lysate (50 ÌL, equivalent to 200 Ìg
protein) was mixed with 50 ÌL 2x reaction buffer (MBL) containing
substrates for caspase-3 (DEVD-pNA (p-nitroanilide)), caspase-8
(IETD-pNA) or caspase-9 (LEHD-pNA). After incubation for two
hours at 37ÆC, the absorbance at 405 nm of the liberated
chromophore pNA was measured by plate reader (16, 18, 20). 
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Figure 3. Induction of DNA fragmentation by two trichloroacetylazulenes [2d, 4c]. Near confluent HL-60 (upper panel) or HSC-4 cells (low panel)
were incubated for 6 hours with or without (cont) the indicated concentrations of [2d], [4c] or 1 Ìg/mL actinomycin D (Act-D) (positive control). DNA
was then extracted and applied to agarose gel electrophoresis. Marker DNA was run in lane 11. One representative example from three independent
experiments is shown.
Determination of polyamines. The cells were harvested by 0.25%
trypsin-0.025%EDTA in PBS(-), washed twice with PBS(-), and
extracted with 10% TCA. After centrifugation for five minutes at
10,000 xg, the deproteinized supernatant was collected and stored at
–40ÆC. The polyamines in the supernatant were determined by
HPLC, after Dansyl-derivatization. Cadaverin-2HCl was used as
internal standard (IS). A modified procedure of dansylation was
performed according to a previously described method (36). Then
50 ÌL of the supernatant (or of the standard solution), 10 ÌL internal
standard solution, 50 ÌL of saturated Na2CO3 solution and 100 ÌL of
dansyl chloride (DNS) solution (10 mg/mL acetone) were added.
After being vortexed, the mixing was continued for one hour at room
temperature. Excess DNS was neutralized by reaction with proline
(150 mg/mL). The dansylated derivatives were extracted into 0.2 mL
of toluene. The extract was evaporated in airflow, and the residue was
dissolved in 200 ÌL 80% CH3CN/H2O, and 10 ÌL was injected into a
HPLC system. HPLC separation was performed with a Column
SHISEIDO CAPCELL PAK C18 (4.6 mm I.D., 35 mm in length). The
mobile phase for elution was a linear gradient between 50%
acetonitrile in water (mobile phase A) and 80% acetontrile in water
(mobile phase B), the time program was described below (0-5 min, A
100%; 5-13 min, A 100 %-0 %; 13-20 min, A 0%; 20-25 min, A 100%)
at a flow rate at 0.7 mL/min. Fluorescence intensity was detected at
excitation at 337 nm, and emission at 521 nm. 
Construction of plasmids. cDNA encoding LC3 was obtained by RT-
PCR from the total RNA of HSC-2 cells with the LC3 sense primer (5'
-GGGAATTCATGCCGTCGGAGAAGACCTT-3') and LC3
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Figure 4. Electron microscopy of control and dying HSC-4 cells. HSC-4
cells were incubated for 4 hours without (G) or with 38.3 (A), 76.6 (B)
or 153.2 (C) ÌM [2d], or 113.4 (D), 226.8 (E) or 435.6(F) ÌM [4c], and
then processed for the electron microscopy. Bar: 2 Ìm.
antisense primer (5'-GGGAATTCTAGATTACACTGACAATTT
CATCC-3'). It was subcloned into the EcoRI site of pAcGFP1-C2, a
GFP fusion protein expression vector (Clontech Laboratories, Inc.,
Mountain View, CA, USA). The plasmid constructs was verified by
DNA sequencing using the Applied Biosystems 310 DNA sequencer.
Transfection. HSC-4 cells were seeded at 0.5x106 cells/well in a 24
well plate, and the next day, the cells were transfected with a
mixture of 1.5 Ìg of plasmid DNA and 0.7 Ìl of Lipofectamineì
2000 (Invitrogen Corp., Carlsbad, CA, USA). After transfection for
18 hours, the cells were used for each experiment.
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Figure 5. Effect of [2d] and [4c] on the cytoplasmic accumulation of LC3-GFP. HSC-4 cells
were incubated for 3 hours without (control) or with the indicated concentrations of [2d] or [4c]. 
Assay for LC3 accumulation to the autophagosome. GFP-LC3
transfected HSC-4 cells were observed by a Laser Scanning
Microscope LSM510 (Carl Zeiss Inc., Gottingen, Germany),
using the following filters: excitation filter 488 nm, emission filter
505-530 nm. 
Detection of acidic vesicular organelles with acridine orange staining.
Acidic vesicular organelles were stained with acridine orange
(Sigma Chemical Co.) as described previously (37, 38). HSC-4 cells
were stained with 1 Ìg/mL acridine orange for 15 minutes. Samples
were then examined under a laser scanning microscope LSM510,
using the following filter: excitation filter 488 nm, emission filter
505-530 nm and >650 nm.
Electron microscopy. The cells were harvested by 0.25% trypsin-
0.025%EDTA in PBS(-), and pelleted by centrifugation at 1,000
rpm for five minutes. The cells were fixed for one hour with 2%
glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) at 4ÆC,
postfixed for one hour with 1% osmium tetraoxide-0.1 M
cacodylate buffer (pH 7.4) at 4ÆC, dehydrated, then embedded in
Araldite 502 (CIBA-GEIGY, Basel, Swiss; NISSHIN EN Co.
Ltd., Tokyo, Japan). Fine sections were stained with uranyl
acetate and lead citrate, and then observed under a JEM-1210
electron microscope (JEOL, Tokyo, Japan) at an accelerating
voltage of 100 KV (39).
Results
Structure and activity relationship. There was no apparent
difference in the cytotoxic activity between the 2-
methoxyazulenes [1a-1e, 2a-2e] and the 2-ethoxyazulenes
[3a-3e, 4a-4e] (Table I). The trichloroacetylazulenes [2a-2e,
4a-4e] generally showed higher cytotoxicity and tumor-
specificity (expressed as a TS value) as compared with the
corresponding trifluoroacetylazulenes [1a-1e, 3a-3e]. In
particular, the trifluoroacetylazulenes [1a, 1b, 1d, 1e, 3a, 3b]
showed much lower cytotoxic activity whereas 1-
trichloroacetyl-3-bromo-2-ethoxyazulene [4d] and 1-
trichloroacetyl-2-ethoxy-3-iodoazulene [4e] showed the
highest cytotoxicity for both normal and tumor cells (Table
I). In general, trichloroacetylazulenes have shown higher
cytotoxicity than tropolone (18) and azulenequinones (20).
Trifluoroace-tylazulenes have shown generally lower cytotoxic
activity than the corresponding azulenes (16). Substitution of
chloride [1c, 2c, 3c. 4c], bromide [1d, 2d, 3d, 4d] or iodine
[1e, 2e, 3e, 4e] at the C-3 position further enhanced their
cytotoxicity activity against four tumor cell lines especially the
HL-60 cells. Among the twenty compounds, compounds [2d]
and [4c] showed the highest tumor specificity (TS=>3.5 and
>2.5, respectively) (Table I). 
Apoptosis induction in HL-60 cells. Compounds [2d] and
[4c] induced caspase-3, -8 and -9 activation (Figure 2)
and internucleosomal DNA fragmentation (Figure 3) in
HL-60 cells. On the other hand, these compounds induced
these apoptosis markers less efficiently in HSC-4 cells
(Figures 2, 3). 
Induction of autophagic cell death in HSC-4 cells. Transmission
electron microscopy showed that compounds [2d] and [4c]
induced vacuolization, without affecting the cell surface
microvilli and nuclear membrane except at the highest
concentration in HSC-4 cells (Figure 4). Compounds [2d] and
[4c] induced the translocation of the LC3-GFP fusion protein
into autophagosome (Figure 5). However, transient expression
of LC3-GFP may cause severe cellular damage at higher
concentration. Therefore, the possibility of autophagy
induction by another method, a labeling of acidic vesicular
organelles, such as autophagosomes, by acridine orange (37,
38) was tested. Compounds [2d] and [4c] induced the
granular distribution of acridine orange in the autophagosome
of HSC-4 cells, further supporting the occurrence of
autophagy. It is interesting to note that there was an optimal
concentration of acridine staining, since the acridine staining
intensity declined at higher concentration (Figure 6). The
cytotoxic activity of [4c], but not [2d], was slightly reduced by
3-methyladenine, an inhibitor of autophagy (Figure 7). 
We have previously reported that the intracellular
concentration of putrescine declined during the apoptotic
cell death of HL-60 cells (40, 41). Therefore, we investigated
whether compounds [2d] and [4c] induce similar change in
the putrescine level. These compounds failed to induce the
decline of putrescine and other polyamines (spermidine,
spermine) in HSC-4 cells (Figure 8). 
Discussion
The present study demonstrated that all ten
trichloroacetylazulenes show higher cytotoxic activity
against tumor cell lines than the corresponding ten
trifluoroacetylazulenes, confirming our previous finding
(23). The cytotoxic activity was significantly enhanced by
the addition of a chlorine, bromine or iodine atom at the
C-3 position. The HL-60 cells were found to be one order
more sensitive to these compounds with extra halogen than
the other oral squamous cell carcinoma cell lines, and the
HL-60 cells were induced to undergo apoptosis by
treatment with either compounds [2d] or [4c]. The
activation of all caspase-3, -8 and -9 by these compounds
suggests the activation of both mitochondria-independent
(extrinsic) and -dependent (intrinsic) pathways (42). The
extremely higher sensitivity of HL-60 cells to compounds
[2d] and [4c] strongly suggests the applicability of these
halogenated compounds for the treatment of leukemia
cells, although further studying with various leukemic cell
lines is necessary.
On the other hand, compounds [2d] or [4c] did not induce
apoptotic markers so clearly in the HSC-4 cells. The much
lower activation of caspases suggests the induction of non-
apoptotic cell death (43). Compounds [2d] and [4c] induced
vacuolization, and the granular distribution of acridine orange
and translocation of the LC3-GFP into the autophagosome of
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HSC-4 cells. The cell death induced by compound [4c], but
not [2d], was slightly reduced by the addition of 3-
methyladenine, an inhibitor of autophagy. This suggests the
induction of autophagy in HSC-4 cells, at least to some extent.
The present study has demonstrated that both compounds
[2d] or [4c] induced apoptotic cell death in HL-60 cells,
whereas they induced autophagic cell death in HSC-4 cells.
Since HSC-4 cells are much more resistant to these
compounds, the induction of autophagic cell death may be
coupled to the extent of drug resistance. This is supported
by the induction of autography in malignant brain tumor cell
lines, that are resistant to many of anticancer drugs (38, 44).
The intracellular level of putrescine did not decline
during the autophagic cell death of the HSC-4 cells. This
suggests that the decline of putrescine may be specific to
apoptotic cell death, rather than to other types of cell death.
More experiments are required to confirm this point.
In conclusion, it was found that the trihaloacetylazulene
derivatives induced different type of cell death, depending
on the type of cells. Further studying is required to clarify
the action mechanisms by which such diversity is
produced. 
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Figure 6. Effect of [2d] and [4c] on the cytoplasmic accumulation of acridine orange. HSC-4 cells were
incubated for 4 hours without (control) or with the indicated concentrations of [2d] or [4c]. Excitation
filter 488 nm, emission filter 505-530 nm (green) and >650 nm (red).
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Figure 7. Effect of 3-methyladenine on [2d] or [4c]-induced cytotoxicity. HSC-4 cells were incubated for 24 hours with the indicated concentrations of
[2d] or [4c] in the presence of 0 (◆), 1 (■), 5 (▲) or 10 (●) mM 3-methyladenine (3MA), and the viable cell number was determined by MTT method.
Data was corrected for 3-methyladenine cytotoxicity. Each value represents mean from three determinants.
Figure 8. Effect of [4c] on the intracellular concentration of polyamines. HSC-4 cells were incubated for 4 hours with the indicated concentrations of
[4c], and the intracellular concentration of polyamine was determined by HPLC. Each value represents the mean from six determinants. put: putrescine,
spd: spermidine, spm: spermine.
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